Fatty Acid Transfer from Blood to Milk Is Disrupted in Mothers with Low Milk Production, Obesity, and Inflammation.
TNF-α
fatty acids
inflammation
lactation
lipoprotein lipase
low milk supply
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
14 01 2023
14 01 2023
Historique:
received:
27
06
2022
revised:
26
08
2022
accepted:
22
09
2022
pubmed:
9
10
2022
medline:
18
1
2023
entrez:
8
10
2022
Statut:
ppublish
Résumé
Obesity is associated with chronic inflammation and is a risk factor for insufficient milk production. Inflammation-mediated suppression of LPL could inhibit mammary uptake of long-chain fatty acids (LCFAs; >16 carbons). In an ancillary case-control analysis, we investigated whether women with low milk production despite regular breast emptying have elevated inflammation and disrupted transfer of LCFAs from plasma into milk. Data and specimens from a low milk supply study and an exclusively breastfeeding control group were analyzed, with milk production measured by 24-h test-weighing at 2-10 wk postpartum. Low milk supply groups were defined as very low (VL; <300 mL/d; n = 23) or moderate (MOD; ≥300 mL/d; n = 20) milk production, and compared with controls (≥699 mL/d; n = 18). Serum and milk fatty acids (weight% of total) were measured by GC, serum and milk TNF-α by ELISA, and serum high-sensitivity C-reactive protein (hsCRP) by clinical analyzer. Group differences were assessed by linear regression models, chi-square exact tests, and Kruskal-Wallis nonparametric tests. VL cases, as compared with MOD cases and controls, had higher prevalence of elevated serum hsCRP (>5 mg/L; 57%, 15%, and 22%, respectively; P = 0.004), detectable milk TNF-α (67%, 32%, and 33%, respectively; P = 0.04), and obesity (78%, 40%, and 22%, respectively; P = 0.003). VL cases had lower mean ± SD LCFAs in milk (60% ± 3%) than MOD cases (65% ± 4%) and controls (66% ± 5%) (P < 0.001). Milk and serum LCFAs were strongly correlated in controls (r = 0.82, P < 0.001), but not in the MOD (r = 0.25, P = 0.30) or VL (r = 0.20, P = 0.41) groups (Pint < 0.001). Mothers with very low milk production have significantly higher obesity and inflammatory biomarkers, lower LCFAs in milk, and disrupted association between plasma and milk LCFAs. These data support the hypothesis that inflammation disrupts normal mammary gland fatty acid uptake. Further research should address impacts of inflammation and obesity on mammary fatty acid uptake for milk production.
Sections du résumé
BACKGROUND
Obesity is associated with chronic inflammation and is a risk factor for insufficient milk production. Inflammation-mediated suppression of LPL could inhibit mammary uptake of long-chain fatty acids (LCFAs; >16 carbons).
OBJECTIVES
In an ancillary case-control analysis, we investigated whether women with low milk production despite regular breast emptying have elevated inflammation and disrupted transfer of LCFAs from plasma into milk.
METHODS
Data and specimens from a low milk supply study and an exclusively breastfeeding control group were analyzed, with milk production measured by 24-h test-weighing at 2-10 wk postpartum. Low milk supply groups were defined as very low (VL; <300 mL/d; n = 23) or moderate (MOD; ≥300 mL/d; n = 20) milk production, and compared with controls (≥699 mL/d; n = 18). Serum and milk fatty acids (weight% of total) were measured by GC, serum and milk TNF-α by ELISA, and serum high-sensitivity C-reactive protein (hsCRP) by clinical analyzer. Group differences were assessed by linear regression models, chi-square exact tests, and Kruskal-Wallis nonparametric tests.
RESULTS
VL cases, as compared with MOD cases and controls, had higher prevalence of elevated serum hsCRP (>5 mg/L; 57%, 15%, and 22%, respectively; P = 0.004), detectable milk TNF-α (67%, 32%, and 33%, respectively; P = 0.04), and obesity (78%, 40%, and 22%, respectively; P = 0.003). VL cases had lower mean ± SD LCFAs in milk (60% ± 3%) than MOD cases (65% ± 4%) and controls (66% ± 5%) (P < 0.001). Milk and serum LCFAs were strongly correlated in controls (r = 0.82, P < 0.001), but not in the MOD (r = 0.25, P = 0.30) or VL (r = 0.20, P = 0.41) groups (Pint < 0.001).
CONCLUSIONS
Mothers with very low milk production have significantly higher obesity and inflammatory biomarkers, lower LCFAs in milk, and disrupted association between plasma and milk LCFAs. These data support the hypothesis that inflammation disrupts normal mammary gland fatty acid uptake. Further research should address impacts of inflammation and obesity on mammary fatty acid uptake for milk production.
Identifiants
pubmed: 36208911
pii: S0022-3166(23)08660-1
doi: 10.1093/jn/nxac220
pmc: PMC9840005
doi:
Substances chimiques
Fatty Acids
0
C-Reactive Protein
9007-41-4
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2716-2726Subventions
Organisme : NIH HHS
ID : K12 HD051953
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Am J Clin Nutr. 2010 Sep;92(3):574-84
pubmed: 20573792
Food Chem Toxicol. 2020 Jul;141:111299
pubmed: 32283198
Pediatrics. 2012 Mar;129(3):e827-41
pubmed: 22371471
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Br J Nutr. 2020 Apr 28;123(8):841-848
pubmed: 31964441
Am J Clin Nutr. 2014 Jan;99(1):115-21
pubmed: 24196401
Am J Clin Nutr. 2007 Aug;86(2):404-11
pubmed: 17684212
Endocrinology. 1996 Nov;137(11):4915-24
pubmed: 8895364
Am J Clin Nutr. 2017 Jul;106(Suppl 1):359S-371S
pubmed: 28615259
Inflamm Bowel Dis. 2022 Nov 2;28(11):1717-1724
pubmed: 35099541
J Natl Cancer Inst. 2015 Apr 28;107(7):
pubmed: 25921910
Isotopes Environ Health Stud. 2016 Jun;52(3):270-80
pubmed: 26444910
PLoS One. 2019 May 29;14(5):e0217085
pubmed: 31141526
Pediatr Res. 2020 Jan;87(1):32-41
pubmed: 31288249
Ann N Y Acad Sci. 1990;587:325-31
pubmed: 2193578
Am J Physiol Endocrinol Metab. 2016 Aug 1;311(2):E405-22
pubmed: 27354238
Am J Clin Nutr. 2001 Aug;74(2):242-7
pubmed: 11470727
Clin Nutr. 2019 Oct;38(5):2436-2441
pubmed: 30502974
J Clin Endocrinol Metab. 1991 Apr;72(4):934-44
pubmed: 2005221
Breastfeed Med. 2020 Oct;15(10):630-638
pubmed: 32700964
Matern Child Nutr. 2019 Jul;15(3):e12756
pubmed: 30472802
Int J Pediatr. 2021 Feb 22;2021:8883618
pubmed: 33679996
J Lipid Res. 2020 Aug;61(8):1161-1167
pubmed: 32586846
J Dairy Sci. 2013 Oct;96(10):6621-30
pubmed: 23958016
J Pediatr Gastroenterol Nutr. 1984;3(1):108-22
pubmed: 6363664
Best Pract Res Clin Endocrinol Metab. 2018 Jan;32(1):57-68
pubmed: 29549961
Am J Clin Nutr. 2021 Oct 4;114(4):1523-1534
pubmed: 34254983
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Nutr Rev. 2002 Aug;60(8):235-51
pubmed: 12199299
Adv Nutr. 2016 Mar 15;7(2):407-14
pubmed: 26980825
J Perinatol. 2016 Apr;36(4):284-90
pubmed: 26741571
Int J Obes Relat Metab Disord. 2002 May;26(5):652-8
pubmed: 12032749
J Lipid Res. 2003 Mar;44(3):455-63
pubmed: 12562865
J Hum Lact. 2018 May;34(2):226-231
pubmed: 29543558
PLoS One. 2019 Jan 25;14(1):e0210610
pubmed: 30682200
Annu Rev Nutr. 1997;17:159-83
pubmed: 9240924
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):126-131
pubmed: 29154942
Breastfeed Med. 2018 Dec;13(10):702-710
pubmed: 30325649
Am J Clin Nutr. 2003 Apr;77(4):931-6
pubmed: 12663294
Nature. 1985 Aug 8-14;316(6028):552-4
pubmed: 2993897
Nutrients. 2020 Feb 06;12(2):
pubmed: 32041195
Prev Med. 2018 Sep;114:140-148
pubmed: 29953898
Int J Food Sci Nutr. 2020 Mar;71(2):186-192
pubmed: 31423865
Biochim Biophys Acta. 1977 May 25;487(2):297-306
pubmed: 861238
J Trace Elem Med Biol. 2018 Mar;46:55-61
pubmed: 29413111
Breastfeed Med. 2012 Feb;7(1):43-9
pubmed: 21524193
Am J Physiol Endocrinol Metab. 2004 May;286(5):E711-7
pubmed: 14693508
Annu Rev Nutr. 1988;8:63-79
pubmed: 3060180
Breastfeed Med. 2020 Jan;15(1):56-62
pubmed: 31765240
Neoplasia. 2021 Feb;23(2):197-209
pubmed: 33383310
Breastfeed Med. 2021 Apr;16(4):349-350
pubmed: 33852344
Am J Clin Nutr. 1978 Jul;31(7):1127-30
pubmed: 665562
J Nutr. 1999 Aug;129(8):1574-8
pubmed: 10419993
Pediatrics. 1991 Jun;87(6):829-37
pubmed: 2034486
Breastfeed Med. 2016 Mar;11(2):80-5
pubmed: 26859784
J Lipid Res. 1998 Jul;39(7):1389-96
pubmed: 9684741
J Hum Lact. 2019 May;35(2):261-271
pubmed: 30629889
Pediatrics. 2008 May;121(5):e1319-24
pubmed: 18450874
Ochsner J. 2016 Winter;16(4):511-524
pubmed: 27999511
J Mammary Gland Biol Neoplasia. 2014 Dec;19(3-4):271-88
pubmed: 26084427
J Nutr. 2000 Dec;130(12):2972-80
pubmed: 11110856
Breastfeed Med. 2022 Jul;17(7):566-576
pubmed: 35475660
PLoS One. 2021 Mar 24;16(3):e0248754
pubmed: 33760869
Pediatrics. 2004 May;113(5):e465-71
pubmed: 15121990
Matern Child Nutr. 2008 Jul;4(3):163-70
pubmed: 18582350
Pediatrics. 2008 Oct;122 Suppl 2:S69-76
pubmed: 18829834
Lipids. 1997 Nov;32(11):1219-28
pubmed: 9397408
Pediatr Res. 2017 Apr;81(4):556-564
pubmed: 27814344
Br J Nutr. 2019 Jun;121(12):1431-1440
pubmed: 30975227
Am J Physiol Endocrinol Metab. 2020 Mar 1;318(3):E392-E404
pubmed: 31910030
Adv Nutr. 2018 May 1;9(suppl_1):313S-331S
pubmed: 29846527
Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1726-32
pubmed: 12377756
J Lipid Res. 1989 Dec;30(12):1917-23
pubmed: 2695592
Trop Med Int Health. 2007 May;12(5):594-602
pubmed: 17445127
Curr Diab Rep. 2014 Feb;14(2):460
pubmed: 24402327